S. Carboni et al. / Tetrahedron: Asymmetry 20 (2009) 1185–1190
1189
4
.3.1. (S,S)-Salen-Co(III)-N-Bn-
Hexane/AcOEt 3:2 R
= 0.50) (76 mg, yield 50%). ½
c 0.094, CHCl ). IR (Nujol) max 3231, 2705, 1672, 1643, 1615,
529, 1377, 1321, 1250, 1207, 1168, 1096, 1015, 897, 739 cm . H
) d 7.84 (s, 1H), 7.44–7.43 (m, 4H), 7.36–7.12 (m, 12H),
.65 (d, 2H, J = 7.3 Hz), 5.16 (m, 1H), 4.66 (dd, 1H, J = 13.6 Hz,
J = 3.8 Hz), 4.12 (dd, 1H, J = 5.9 Hz, J = 3.8 Hz), 4.02 (m, 2H), 3.46
L
-serine-biphenyl-phosphite 3a
23.6 ppm. 31P NMR (CDCl
3
) d 146.6 ppm. HRMS (ESI+) m/z calcd for
23
+
+
(
f
a
ꢂ
¼ ꢁ681:8
[C66
3
H75CoNaN O
7
P] : 1134.45668 [M+Na] ; found: 1134.45474.
D
(
1
3
m
ꢁ1 1
a
4.3.4. (S,S)-Salen-Co(III)-N-Bn-L-serine-(R )-binaphthyl-phos-
phite 3d
NMR (CDCl
6
3
2
D
3
(Hexane/AcOEt 2:1 R
(c 0.055, CHCl ); IR (Nujol)
1377, 1314, 1256, 1168, 1095, 1023, 945; 823, 744 cm . H NMR
(CDCl ) d 8.06–7.59 (m, 3H), 7.80 (s, 1H), 7.59 (d, 1H, J = 8.7 Hz),
f
= 0.40) (75 mg, yield 45%). ½
a
ꢂ
¼ ꢁ1227:3
3
m
max 3221, 2725, 1670, 1652, 1634, 1521,
ꢁ1 1
(
m, 1H), 2.98 (m, 1H), 2.82 (m, 1H), 2.71 (m, 1H), 1.96–1.55 (m,
1
3
4
H), 1.55 (s, 10H), 1.42 (s, 9H), 1.36 (s, 10H), 1.17 (s, 10H) ppm.
) d 179.8, 164.9, 163.5, 163.4, 160.7, 150.1, 149.3,
44.9, 141.2, 137.7, 137.0, 135.2, 131.8, 130.4, 130.3, 130.1, 129.8,
29.7, 129.6, 129.4, 129.1, 128.8, 126.0, 125.7, 125.6, 122.8, 122.5,
22.4, 120.9, 118.1, 117.9, 75.9, 70.6, 65.5, 65.3, 64.89, 64.8, 55.9,
6.2, 34.5, 34.2, 32.0, 31.9, 31.1, 30.3, 29.9, 29.3, 25.0, 24.3 ppm.
C
3
NMR (CDCl
3
7.51–7.45 (m, 2H), 7.42–7.27 (m, 7H), 7.20 (d, 1H, J = 2.4 Hz), 7.09–
6.96 (m, 5H), 6.59–6.57 (m, 3H), 4.85 (m, 1H), 4.59 (m, 1H), 4.17–
4.09 (m, 2H), 3.91 (m, 1H), 3.42 (m, 1H), 2.88–2.75 (m, 2H), 2.61
(m, 1H), 1.99–1.85 (m, 3H), 1.56–1.41 (m, 19H), 1.36–1.34 (m,
1
1
1
3
1
3
3
10H), 1.28–1.25 (m, 1H), 1.22–1.12 (m, 11H) ppm. C NMR (CDCl )
3
1
P NMR (CDCl
3
) d 164.6 ppm. HRMS (ESI+) m/z calcd for [C58
H
71Co-
d 179.2, 164.4, 162.9, 161.2, 159.6, 148.3, 147.0, 144.4, 140.8, 137.1,
136.4, 134.8, 132.7, 132.3, 131.6, 130.8, 130.6, 129.9, 129.8, 129.3,
129.1, 129.0, 128.8, 128.4, 128.3, 126.9, 126.8, 126.4, 126.3, 126.0,
125.6, 125.2, 125.1, 124.5, 123.9, 123.5, 122.6, 75.5, 70.4, 66.3,
66.1, 65.1, 55.5, 35.7, 34.1, 33.7, 31.7, 31.4, 30.6, 29.8, 29.4, 29.0,
+
+
NaN
tion by-product: H NMR (CDCl
.51 (d, 1H, J = 2.4 Hz), 7.44 (d, 1H, J = 2.4 Hz), 7.32 (dd, 1H,
J = 7.4 Hz, J = 1.3 Hz), 7.26 (d, 1H, J = 7.2 Hz), 7.21 (d, 1H, J = 2.4 Hz),
3 7
O P] : 1034.42538 [M+Na] ; found: 1034.42271. Decomposi-
1
3
) d 8.30 (br s, 1H), 8.01 (br s, 1H),
7
3
1
7.17 (d, 1H, J = 2.4 Hz), 7.13–7.04 (m, 2H), 6.99–6.95 (m, 1H), 6.68–
6.64 (m, 1H), 6.14 (d, 1H, J = 7.7 Hz), 5.47 (d, 1H, J = 8.2 Hz), 4.25–
4.18 (m, 1H), 3.73–3-67 (m, 1H), 2.91 (d, 1H, J = 10.5 Hz), 2.78 (d,
1H, J = 9.7 Hz), 2.09–2.05 (m, 2H), 1.96–1.87 (m, 1H), 1.78–1.68 (m,
1H), 1.63–1.49 (m, 2H), 1.48 (s, 9H), 1.43 (s, 9H), 1.40 (s, 9H), 1.22
3
24.5, 23.7 ppm. P NMR (CDCl ) d 144.2 ppm. HRMS(ESI+) m/z calcd
+
+
3 7
for [C66H75CoNaN O P] : 1134.45668 [M+Na] ; found: 1134.45423.
4.4. General procedure for the Pd-catalyzed desymmetrization
of meso-cyclopenten-2-ene-1,4-diol biscarbamate
9
3
1
(
s, 9H) ppm. P NMR (CDCl
3
) d 37.5 ppm.
To a solution of the meso-cyclopenten-2-ene-1,4-diol (10 mg,
0.099 mmol) in 0.5 mL of THF, tosyl isocyanate (35 lL, 0.232 mmol,
0
0
4
.3.2. (S,S)-Salen-Co(III)-N-Bn-
phite 3b
Hexane/AcOEt
L
-serine-3,3 ,5,5 -biphenyl-phos-
2.35 equiv) was added. The mixture was stirred at rt for 15 min to
give a colorless solution and then heated to 55 °C for 1 h. The reac-
tion was cooled back to rt, and triethylamine (14.0 lL, 0.099 mmol,
(
3:1
R
f
= 0.40)
); IR (Nujol)
680, 1645, 1618, 1535, 1380, 1320, 1257, 1212, 1168, 1093, 1015,
(115 mg,
yield
72%).
2
3
½
a
1
ꢂ
¼ ꢁ1050:8 (c 0.077, CHCl
3
m
max 3251, 3232, 2726,
D
1.0 equiv) was added. The resulting white slurry was brought to
the chosen temperature conditions and a solution of tris(dib-
enzylidine acetone)dipalladium(0) chloroform complex (5.1 mg,
ꢁ1
1
8
60, 739 cm
.
3
H NMR (CDCl ) d 7.81 (s, 1H), 7.42 (d, 1H,
J = 2.5 Hz), 7.38–7.28 (m, 4H), 7.27 (d, 1H, J = 2.4 Hz), 7.18 (s, 1H),
7
2
1
2
3
1
1
1
1
3
1
.12–7.11 (m, 2H), 7.06 (s, 1H), 7.00 (d, 1H, J = 2.3 Hz), 6.75 (m,
H), 6.51 (s, 1H), 5.04 (m, 1H), 4.68 (m, 1H), 4.34 (m, 1H), 4.15 (dd,
H, J = 14.3 Hz, J = 7.13 Hz), 4.01–3.92 (m, 2H), 3.52 (m, 1H), 2.89–
.78 (m, 2H), 2.62–2.58 (m, 1H), 2.46 (s, 3H), 2.37 (s, 6H), 2.30 (s,
H), 1.83–1.70 (m, 3H), 1.57 (s, 9H), 1.50 (s, 9H), 1.36 (s, 10H),
4.94 lmol) and ligand (20.25 lmol) in 0.5 mL of THF was added
(the solution of the Pd-source and the ligand was prepared under
nitrogen and stirred for 40 min at rt, 10 min at 55 °C and finally
cooled back to rt). The reaction solution was stirred for 30 min.
The solvent was removed in vacuo and purified by flash
chromatography on a short pad of silica gel (10 cm, hexane/AcOEt
80:20) gave the desired products as a slightly brown solid. Conver-
sions were determined by NMR analysis of the crude reaction mix-
ture. Enantiomeric excesses were determined by chiral HPLC
(column Chiralcel OD-H, n-hexane/2-propanol 90:10, flow 0.6 ml/
min).
.23–1.17 (m, 11H) ppm. 13C NMR (CDCl
3
) d 179.3, 164.8, 163.5,
47.4, 145.0, 144.8, 141.2, 137.6, 135.6, 135.1, 134.8, 133.9, 132.1,
31.9, 131.3, 131.2, 130.7, 130.4, 130.2, 129.6, 129.5, 129.0, 128.4,
27.7, 126.0, 122.8, 118.2, 75.9, 71.0, 66.3, 66.1, 65.9, 60.8, 55.9,
6.1, 34.6, 34.1, 32.2, 31.9, 31.3, 30.3, 29.9, 29.5, 25.0, 23.9, 21.3,
7.4, 16.9, 14.6 ppm. 31P NMR (CDCl
) d 150.7 ppm. HRMS (ESI+)
3
+
+
m/z calcd for [C62
H
79CoNaN
3
O
7
P] : 1090.48798 [M+Na] ; found:
1
090.48576.
Acknowledgments
4
.3.3. (S,S)-Salen-Co(III)-N-Bn-L-serine-(S )-binaphthyl-phos-
a
We thank the European Commission [EST-project ‘Foldamers’
MEST-CT-2004-515968 and RTN Network (R)Evolutionary Cataly-
sis MRTN-CT-2006-035866] for financial support. The Università
degli Studi dell’Insubria is gratefully acknowledged for a post-doc-
toral fellowship (assegno di ricerca) to L.P. C.G. thanks Merck Re-
search Laboratories for the Merck’s Academic Development
Program Award.
phite 3c
2
D
2
(
Hexane/AcOEt 2:1 R
f
= 0.40) (62 mg, yield 37%). ½
a
ꢂ
¼ ꢁ775:2
(c 0.078, CHCl
3
); IR (Nujol) max 3159, 2722, 1660, 1634, 1615,
m
ꢁ
1 1
1
526, 1365, 1321, 1255, 1230, 1168, 945, 828, 730 cm . H NMR
(
CDCl
3
) d 8.06 (d, 1H, J = 8.8 Hz), 7.97 (d, 1H, J = 8.3 Hz), 7.87 (d, 1H,
J = 8.5 Hz), 7.82 (d, 1H, J = 8.8 Hz), 7.77 (m, 1H), 7.62 (d, 1H,
J = 8.7 Hz), 7.50–7.33 (m, 9H), 7.31–7.26 (m, 3H), 7.13 (d, 1H,
J = 8.7 Hz), 7.08–7.06 (m, 2H), 6.73 (m, 2H), 5.32 (m, 1H), 4.67 (m,
1
2
1
References
H), 4.16–4.04 (m, 3H), 3.59 (m, 1H), 3.46 (m, 1H), 2.80 (m, 1H),
.73–2.68 (m, 2H), 1.77–1.63 (m, 3H), 1.54 (s, 9H), 1.42 (s, 9H),
1.
Larrow, J. R.; Jacobsen, E. N. Top. Organomet. Chem. 2004, 6, 123–152. and
1
3
.41–1.35 (m, 2H), 1.33 (s, 9H), 1.19–1.12 (m, 10H) ppm. C NMR
) d 179.2, 164.4, 163.1, 162.9, 160.7, 152.0, 147.7, 146.8,
references therein.
(
CDCl
3
2. (a) Reeve, T. B.; Cros, J.-P.; Gennari, C.; Piarulli, U.; de Vries, J. G. Angew. Chem.,
Int. Ed. 2006, 45, 2449–2453; (b) Dzygiel, P.; Reeve, T. B.; Piarulli, U.; Krupicka,
M.; Tvaroska, I.; Gennari, C. Eur. J. Org. Chem. 2008, 1253–1264; For the
1
1
1
1
3
44.5, 140.8, 137.3, 136.9, 134.8, 132.9, 132.1, 131.7, 131.0, 130.7,
30.5, 130.4, 130.2, 129.9, 129.8, 129.3, 128.6, 128.5, 128.4, 127.2,
27.0, 126.6, 126.5, 126.2, 125.7, 125.4, 124.9, 122.1, 122.0, 121.6,
19.3, 118.0, 117.7, 75.5, 69.7, 64.6, 64.5, 63.6, 63.5, 55.4, 35.8,
4.1, 33.7, 31.6, 31.4, 30.4, 30.1, 29.8, 29.5, 29.1, 28.5, 24.4,
3
extension of this method to the resolution of racemic N-benzyl b -amino acids,
see: (c) Dzygiel, P.; Monti, C.; Piarulli, U.; Gennari, C. Org. Biomol. Chem. 2007, 5,
3464–3471.
3.
Nielsen, P. C. L.; Stevenson, P. C.; Blackmond, D. G.; Jacobsen, E. N. J. Am. Chem.
Soc. 2004, 126, 1360–1362.